12/4
07:40 pm
axsm
Form 4 Axsome Therapeutics, For: Dec 02 Filed by: TABUTEAU HERRIOT
Low
Report
Form 4 Axsome Therapeutics, For: Dec 02 Filed by: TABUTEAU HERRIOT
12/4
05:11 pm
axsm
Form 144 Axsome Therapeutics, Filed by: TABUTEAU HERRIOT
Low
Report
Form 144 Axsome Therapeutics, Filed by: TABUTEAU HERRIOT
12/3
05:58 pm
axsm
Form 144 Axsome Therapeutics, Filed by: TABUTEAU HERRIOT
Low
Report
Form 144 Axsome Therapeutics, Filed by: TABUTEAU HERRIOT
12/2
05:14 pm
axsm
Form 144 Axsome Therapeutics, Filed by: TABUTEAU HERRIOT
Medium
Report
Form 144 Axsome Therapeutics, Filed by: TABUTEAU HERRIOT
11/5
07:19 pm
axsm
Form 144 Axsome Therapeutics, Filed by: TABUTEAU HERRIOT
Low
Report
Form 144 Axsome Therapeutics, Filed by: TABUTEAU HERRIOT
11/5
07:01 pm
axsm
Form 4 Axsome Therapeutics, For: Nov 03 Filed by: TABUTEAU HERRIOT
Low
Report
Form 4 Axsome Therapeutics, For: Nov 03 Filed by: TABUTEAU HERRIOT
11/4
05:48 pm
axsm
Form 144 Axsome Therapeutics, Filed by: TABUTEAU HERRIOT
Low
Report
Form 144 Axsome Therapeutics, Filed by: TABUTEAU HERRIOT
11/3
05:56 pm
axsm
Form 144 Axsome Therapeutics, Filed by: TABUTEAU HERRIOT
Low
Report
Form 144 Axsome Therapeutics, Filed by: TABUTEAU HERRIOT
11/3
04:45 pm
axsm
Form S-3ASR Axsome Therapeutics,
Low
Report
Form S-3ASR Axsome Therapeutics,
11/3
04:38 pm
axsm
Form 10-Q Axsome Therapeutics, For: Sep 30
Low
Report
Form 10-Q Axsome Therapeutics, For: Sep 30
11/3
07:07 am
axsm
Form 8-K Axsome Therapeutics, For: Nov 03
Low
Report
Form 8-K Axsome Therapeutics, For: Nov 03
10/8
09:08 pm
axsm
Form 4 Axsome Therapeutics, For: Oct 06 Filed by: TABUTEAU HERRIOT
Low
Report
Form 4 Axsome Therapeutics, For: Oct 06 Filed by: TABUTEAU HERRIOT
10/8
04:55 pm
axsm
Form 144 Axsome Therapeutics, Filed by: TABUTEAU HERRIOT
Medium
Report
Form 144 Axsome Therapeutics, Filed by: TABUTEAU HERRIOT
10/7
04:44 pm
axsm
Form 144 Axsome Therapeutics, Filed by: TABUTEAU HERRIOT
Low
Report
Form 144 Axsome Therapeutics, Filed by: TABUTEAU HERRIOT
10/6
04:48 pm
axsm
Form 144 Axsome Therapeutics, Filed by: TABUTEAU HERRIOT
Low
Report
Form 144 Axsome Therapeutics, Filed by: TABUTEAU HERRIOT
9/22
07:00 pm
axsm
Form 4 Axsome Therapeutics, For: Sep 22 Filed by: Jacobson Mark L.
Low
Report
Form 4 Axsome Therapeutics, For: Sep 22 Filed by: Jacobson Mark L.
9/22
04:14 pm
axsm
Form 144 Axsome Therapeutics, Filed by: Jacobson Mark L.
Low
Report
Form 144 Axsome Therapeutics, Filed by: Jacobson Mark L.
9/17
07:00 pm
axsm
Form 4 Axsome Therapeutics, For: Sep 16 Filed by: Jacobson Mark L.
Low
Report
Form 4 Axsome Therapeutics, For: Sep 16 Filed by: Jacobson Mark L.
9/16
07:37 pm
axsm
Form 4 Axsome Therapeutics, For: Sep 12 Filed by: TABUTEAU HERRIOT
Low
Report
Form 4 Axsome Therapeutics, For: Sep 12 Filed by: TABUTEAU HERRIOT
9/16
05:39 pm
axsm
Form 144 Axsome Therapeutics, Filed by: Jacobson Mark L.
Low
Report
Form 144 Axsome Therapeutics, Filed by: Jacobson Mark L.
9/16
04:47 pm
axsm
Form 144 Axsome Therapeutics, Filed by: TABUTEAU HERRIOT
Medium
Report
Form 144 Axsome Therapeutics, Filed by: TABUTEAU HERRIOT
9/15
06:35 pm
axsm
Form 144 Axsome Therapeutics, Filed by: TABUTEAU HERRIOT
Low
Report
Form 144 Axsome Therapeutics, Filed by: TABUTEAU HERRIOT
9/12
07:20 pm
axsm
Form 144 Axsome Therapeutics, Filed by: TABUTEAU HERRIOT
Low
Report
Form 144 Axsome Therapeutics, Filed by: TABUTEAU HERRIOT
9/9
08:12 pm
axsm
Form 4 Axsome Therapeutics, For: Sep 08 Filed by: Coleman Mark
Low
Report
Form 4 Axsome Therapeutics, For: Sep 08 Filed by: Coleman Mark
9/5
07:43 pm
axsm
Form 4 Axsome Therapeutics, For: Sep 05 Filed by: Saad Mark E
Low
Report
Form 4 Axsome Therapeutics, For: Sep 05 Filed by: Saad Mark E